Acessos vasculares para hemodiálise: análise de dados da clínica Diaverum em Sergipe
Authors:
- Victória Rezende de BritoVBVictória Rezende de Brito
- Maria Bernadete Galrão de Almeida FigueiredoMFMaria Bernadete Galrão de Almeida Figueiredo
- Ronmel Lisboa dos SantosRSRonmel Lisboa dos Santos
- Joaquim Sabino Ribeiro Chaves SobralJSJoaquim Sabino Ribeiro Chaves Sobral
- Aglaé Travassos AlbuquerqueAAAglaé Travassos Albuquerque
- Larissa Garcez de OliveiraLOLarissa Garcez de Oliveira
- Bruna Sueli Aguiar Pereira AraújoBABruna Sueli Aguiar Pereira Araújo
- Giovanna Freitas MunarettoGMGiovanna Freitas Munaretto
- Matheus Garcez Vieira GuimarãesMGMatheus Garcez Vieira Guimarães
Open Access
- 27 November 2022
- journal article
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (16)
Abstract
Patients with acute renal failure or end-stage chronic kidney disease require renal replacement therapy that can be performed by peritoneal dialysis, hemodialysis (HD), or kidney transplantation. Venous access is essential for hemodialysis and can be performed using Central Venous Catheters (CVC), arterialization of a native vein or by interposition of a graft. Several comorbidities such as diabetes, peripheral arterial disease, obesity and others negatively interfere with the success of vascular access, especially in native arteriovenous fistula. Previous use of CVC is associated with failure to make an AVF. When HD is the option, the creation of an FAV should be as brief as possible, with rare exceptions. Thus, the study aims to evaluate the epidemiological and clinical variables of patients undergoing arteriovenous fistula at the Diaverum institution, in the state of Sergipe, and comparatively analyze temporary and permanent vascular access . As a result, we could observe a higher rate of patients who started hemodialysis by CVC and a higher rate of complications was observed. In addition, it can also be noted that in patients who started treatment with AVF, there was a longer duration of the fistula in the long term than those who started with a catheter. With these results, we were able to conclude that every vascular access in the patient who has advanced CKD and in patients who already undergo hemodialysis must take into account several factors, and not only the practicality of implantation due to the consequences that it can cause in another access in the future.Keywords
This publication has 20 references indexed in Scilit:
- Research Priorities for Percutaneous Arteriovenous Fistula Creation in Patients with End-Stage Renal Disease: Proceedings and Recommendations from a Multidisciplinary Research Consensus PanelJournal of Vascular and Interventional Radiology, 2021
- Association of early failure of arteriovenous fistula with mortality in hemodialysis patientsScientific Reports, 2021
- Comparison of tunneled central venous catheters and native arteriovenous fistulae by evaluating the mortality and morbidity of patients with prevalent hemodialysisJournal of the Formosan Medical Association, 2019
- Utilization, patency, and complications associated with vascular access for hemodialysis in the United StatesJournal of Vascular Surgery, 2018
- Worldwide access to treatment for end-stage kidney disease: a systematic reviewThe Lancet, 2015
- US Renal Data System 2011 Annual Data ReportAmerican Journal of Kidney Diseases, 2012
- Interventions for preventing infectious complications in haemodialysis patients with central venous cathetersCochrane Database of Systematic Reviews, 2010
- Vascular access use in Europe and the United States: Results from the DOPPSKidney International, 2002
- Vascular access thrombosis in new hemodialysis patientsAmerican Journal of Kidney Diseases, 1995
- Successful use of double-lumen, silicone rubber catheters for permanent hemodialysis accessKidney International, 1989